Skip to main content

Advertisement

Log in

Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication

  • Published:
Virus Genes Aims and scope Submit manuscript

Abstract

Hepatitis C virus (HCV) infection is a major global health issue. Although the search for HCV treatments has resulted in great achievements, the current treatment methods have limitations, and new methods and drugs for hepatitis C treatment are still required. The aim of the present study was to investigate the effects of artesunate (ART) on HCV replication and compared these effects with those of ribavirin (RBV) and interferon-2b (IFN). The study was performed in HCV-infection cell models (JFH1-infected Huh7.5.1 and OR6 cell lines). Our results showed that the antimalarial drug ART inhibited HCV replicon replication in a dose- and time-dependent manner at a concentration that had no effect on the proliferation of exponentially growing host cells, and the inhibitory effect on HCV replication was stronger than RBV but weaker than IFN, as determined by qPCR, luciferase assays, and Western blot analysis. Furthermore, the combination of ART and IFN resulted in a greater inhibition of HCV replication. These findings demonstrated that ART had an inhibitive effect on HCV replication and may be a novel supplemental co-therapy with IFN and RBV for HCV and as an alternative strategy to combat resistance mechanisms that have emerged in the presence of DAA agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. D.L. Thomas, Nat. Med. 19, 850–858 (2013)

    Article  CAS  PubMed  Google Scholar 

  2. A. Craxi, A. Licata, Semin. Liver Dis. 23(Suppl 1), 35–46 (2003)

    PubMed  Google Scholar 

  3. M.G. Ghany, D.R. Nelson, D.B. Strader, D.L. Thomas, L.B. Seeff, Hepatology 54, 1433–1444 (2011)

    Article  PubMed Central  PubMed  Google Scholar 

  4. H.W. Reesink, S. Zeuzem, C.J. Weegink, N. Forestier, A. van Vliet, D.R.J. van de Wetering, L. McNair, S. Purdy, R. Kauffman, J. Alam, P.L. Jansen, Gastroenterology 131, 997–1002 (2006)

    Article  CAS  PubMed  Google Scholar 

  5. J.M. Pawlotsky, Hepatology 53, 1742–1751 (2011)

    Article  CAS  PubMed  Google Scholar 

  6. N.J. White, Science 320, 330–334 (2008)

    Article  CAS  PubMed  Google Scholar 

  7. M. Adjuik, A. Babiker, P. Garner, P. Olliaro, W. Taylor, N. White, Lancet 363, 9–17 (2004)

    Article  CAS  PubMed  Google Scholar 

  8. X. Zhou, W.J. Sun, W.M. Wang, K. Chen, J.H. Zheng, M.D. Lu, P.H. Li, Z.Q. Zheng, Anticancer Drugs 24, 920–927 (2013)

    Article  CAS  PubMed  Google Scholar 

  9. K.T. Batty, T.M. Davis, L.T. Thu, T.Q. Binh, T.K. Anh, K.F. Ilett, J. Chromatogr. B Biomed. Appl. 677, 345–350 (1996)

    Article  PubMed  Google Scholar 

  10. W. Jiang, B. Li, X. Zheng, X. Liu, X. Pan, R. Qing, Y. Cen, J. Zheng, H. Zhou, J. Antibiot. 66, 339–345 (2013)

    Article  CAS  PubMed  Google Scholar 

  11. P.M. O’Neill, G.H. Posner, J. Med. Chem. 47, 2945–2964 (2004)

    Article  PubMed  Google Scholar 

  12. T. Efferth, M.R. Romero, D.G. Wolf, T. Stamminger, J.J. Marin, M. Marschall, Clin. Infect. Dis. 47, 804–811 (2008)

    Article  CAS  PubMed  Google Scholar 

  13. R. Arav-Boger, R. He, C.J. Chiou, J. Liu, L. Woodard, A. Rosenthal, L. Jones-Brando, M. Forman, G. Posner, PLoS One 5, e10370 (2010)

    Article  PubMed Central  PubMed  Google Scholar 

  14. R. He, B.T. Mott, A.S. Rosenthal, D.T. Genna, G.H. Posner, R. Arav-Boger, PLoS One 6, e24334 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. M.R. Romero, T. Efferth, M.A. Serrano, B. Castano, R.I. Macias, O. Briz, J.J. Marin, Antiviral Res. 68, 75–83 (2005)

    Article  CAS  PubMed  Google Scholar 

  16. K.J. Blight, J.A. McKeating, C.M. Rice, J. Virol. 76, 13001–13014 (2002)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann, R. Bartenschlager, Science 285, 110–113 (1999)

    Article  CAS  PubMed  Google Scholar 

  18. L.D. Presser, A. Haskett, G. Waris, Virology 412, 284–296 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. M. Ikeda, K. Abe, H. Dansako, T. Nakamura, K. Naka, N. Kato, Biochem. Biophys. Res. Commun. 329, 1350–1359 (2005)

    Article  CAS  PubMed  Google Scholar 

  20. J. Paeshuyse, L. Coelmont, I. Vliegen, J. Van Hemel, J. Vandenkerckhove, E. Peys, B. Sas, E. De Clercq, J. Neyts, Biochem. Biophys. Res. Commun. 348, 139–144 (2006)

    Article  CAS  PubMed  Google Scholar 

  21. R.S. Miller, Q. Li, L.R. Cantilena, K.J. Leary, G.A. Saviolakis, V. Melendez, B. Smith, P.J. Weina, Malar J. 11, 255 (2012)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. R. Price, M. van Vugt, L. Phaipun, C. Luxemburger, J. Simpson, R. McGready, F. ter Kuile, A. Kham, T. Chongsuphajaisiddhi, N.J. White, F. Nosten, Am. J. Trop. Med. Hyg. 60, 547–555 (1999)

    CAS  PubMed  Google Scholar 

  23. T. Efferth, M. Marschall, X. Wang, S.M. Huong, I. Hauber, A. Olbrich, M. Kronschnabl, T. Stamminger, E.S. Huang, J. Mol. Med. 80, 233–242 (2002)

    Article  CAS  PubMed  Google Scholar 

  24. S.R. Meshnick, Y.Z. Yang, V. Lima, F. Kuypers, S. Kamchonwongpaisan, Y. Yuthavong, Antimicrob. Agents Chemother. 37, 1108–1114 (1993)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. G.H. Posner, C.H. Oh, D. Wang, L. Gerena, W.K. Milhous, S.R. Meshnick, W. Asawamahasadka, J. Med. Chem. 37, 1256–1258 (1994)

    Article  CAS  PubMed  Google Scholar 

  26. J. Choi, K.J. Lee, Y. Zheng, A.K. Yamaga, M.M. Lai, J.H. Ou, Hepatology 39, 81–89 (2004)

    Article  CAS  PubMed  Google Scholar 

  27. T. Zima, M. Kalousova, Alcohol. Clin. Exp. Res. 29, 110S–115S (2005)

    Article  CAS  PubMed  Google Scholar 

  28. D. Burdette, M. Olivarez, G. Waris, J. Gen. Virol. 91, 681–690 (2010)

    Article  CAS  PubMed  Google Scholar 

  29. G. Waris, A. Livolsi, V. Imbert, J.F. Peyron, A. Siddiqui, J. Biol. Chem. 278, 40778–40787 (2003)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Chung (Harvard University) for providing Huh7.5.1 cells and JFH1 and Dr. Zhao (Chinese Academy of Sciences) for providing OR6 cells. This work was supported by Grants from the National Natural Science Fund of China (81370542), Chinese National Key Clinical Specialty Project (No. 2013), and Chinese National Science and Technology Major Project (No. 2008ZX10202, http://www.nmp.gov.cn/) to GZ Gong.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guozhong Gong.

Additional information

Edited by Paul Schnitzler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dai, R., Xiao, X., Peng, F. et al. Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication. Virus Genes 52, 22–28 (2016). https://doi.org/10.1007/s11262-015-1285-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11262-015-1285-7

Keywords

Navigation